Cargando…
Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting
[Image: see text]
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374060/ https://www.ncbi.nlm.nih.gov/pubmed/34748637 http://dx.doi.org/10.1111/bjd.20885 |
| _version_ | 1784767714157395968 |
|---|---|
| author | Papp, K.A. Gooderham, M.J. Albrecht, L.E. Raymond, M.‐A. Lynde, C.W. |
| author_facet | Papp, K.A. Gooderham, M.J. Albrecht, L.E. Raymond, M.‐A. Lynde, C.W. |
| author_sort | Papp, K.A. |
| collection | PubMed |
| description | [Image: see text] |
| format | Online Article Text |
| id | pubmed-9374060 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93740602022-08-17 Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting Papp, K.A. Gooderham, M.J. Albrecht, L.E. Raymond, M.‐A. Lynde, C.W. Br J Dermatol Correspondence [Image: see text] John Wiley and Sons Inc. 2022-01-20 2022-04 /pmc/articles/PMC9374060/ /pubmed/34748637 http://dx.doi.org/10.1111/bjd.20885 Text en © 2021 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Correspondence Papp, K.A. Gooderham, M.J. Albrecht, L.E. Raymond, M.‐A. Lynde, C.W. Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting |
| title | Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting |
| title_full | Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting |
| title_fullStr | Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting |
| title_full_unstemmed | Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting |
| title_short | Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting |
| title_sort | treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374060/ https://www.ncbi.nlm.nih.gov/pubmed/34748637 http://dx.doi.org/10.1111/bjd.20885 |
| work_keys_str_mv | AT pappka treatmentsatisfactionsafetyandeffectivenessofaddingmethotrexatetoadalimumabinpatientswithpsoriasisrespondingsuboptimallytoadalimumabinarealworldsetting AT gooderhammj treatmentsatisfactionsafetyandeffectivenessofaddingmethotrexatetoadalimumabinpatientswithpsoriasisrespondingsuboptimallytoadalimumabinarealworldsetting AT albrechtle treatmentsatisfactionsafetyandeffectivenessofaddingmethotrexatetoadalimumabinpatientswithpsoriasisrespondingsuboptimallytoadalimumabinarealworldsetting AT raymondma treatmentsatisfactionsafetyandeffectivenessofaddingmethotrexatetoadalimumabinpatientswithpsoriasisrespondingsuboptimallytoadalimumabinarealworldsetting AT lyndecw treatmentsatisfactionsafetyandeffectivenessofaddingmethotrexatetoadalimumabinpatientswithpsoriasisrespondingsuboptimallytoadalimumabinarealworldsetting |